The RDAF organizes a workshop on market access

    17 Jan, 2022

    The Rare Disease Action Forum (RDAF) will host a virtual multi-stakeholder workshop on ‘Market access for orphan drugs in Switzerland’ on 26 April 2022 (2:00-5:00 pm).

    On the basis of a fictional case study, workshop participants will be given the opportunity to engage in discussions on the current framework for market access in Switzerland as well as to identify potential areas for improvement and solutions in a multi-stakeholder approach.

    This workshop aims to gather stakeholders from across the field of rare diseases: patient organizations, industry, research organizations, healthcare professionals, public authorities, decision makers and insurers.

    Registration  for the workshop is open.

    Continue reading

    Joint statement on the KVV/OAMal and KLV/OPAS revision

    The RDAF co-signed a joint statement with other stakeholders on the revision of the Health Insurance Ordinance (KVV/OAMal) and Health Benefits Ordinance (KLV/OPAS). The statement highlights the potential negative impacts of the revision, including the following: -...